Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 20 of 83 for “"Pioglitazone"”.

  1. Pharmacokinetics and effect of pioglitazone in obese, insulin-resistant cats

    Pioglitazone is a thiazolidinedione (TZD) insulin sensitizer approved for use in human type 2 diabetes mellitus. In addition to improving glycemic control, lipid profiles, and pancreatic β-cell function in diabetics, pioglitazone decreases hepatic triglyceride content in humans with non-alcoholic …

    uiuc Repository record for Pharmacokinetics and effect of pioglitazone in obese, insulin-resistant cats (opens in a new tab)

  2. An investigation into the antidepressant–like profile of pioglitazone in a genetic rat model of depression

    … (PPAR)- agonists, such as rosiglitazone and pioglitazone. In preclinical studies, however, these effects are limited to acute treatment with pioglitazone or sub-chronic (5 days) treatment with rosiglitazone. It is well-recognized that such findings need to be confirmed by chronic treatment …

    nwu-za Repository record for An investigation into the antidepressant–like profile of pioglitazone in a genetic rat model of depression (opens in a new tab)

  3. Novel strategies for secondary stroke prevention - exploring the use of pioglitazone therapy using a mixed methods approach

    Pioglitazone, an oral thiazolidinedione (TZD), is used in the second- or third-line management of type 2 diabetes mellitus (T2DM). In addition, the Insulin Resistance Intervention after Stroke trial showed that pioglitazone reduced cardiovascular events in people with recent ischaemic stroke or …

    glasgow Repository record for Novel strategies for secondary stroke prevention - exploring the use of pioglitazone therapy using a mixed methods approach (opens in a new tab) Download PDF for Novel strategies for secondary stroke prevention - exploring the use of pioglitazone therapy using a mixed methods approach (opens in a new tab)

  4. A pharmacokinetic and pharmacodynamic study of pioglitazone in a model of induced insulin resistance in normal horses

    … the incidence of laminitis in horses with EMS. Pioglitazone, a thiazolidinedione class of anti-diabetic drug, has proven efficacy in humans with type 2 diabetes, a syndrome of insulin resistance sharing some similarities with EMS. The ability of pioglitazone to influence insulin sensitivity in …

    vt Repository record for A pharmacokinetic and pharmacodynamic study of pioglitazone in a model of induced insulin resistance in normal horses (opens in a new tab)

  5. The Effect Of Pioglitazone On Phosphoproteome And Interactome Of Protein Phosphatase 2a In Primary Human Skeletal Muscle Cells

    … treated with a variety of medications, including Pioglitazone (PIO), a potent insulin sensitizer for skeletal muscle. PIO is a synthetic ligand for the peroxisome proliferator-activated receptor (PPAR-γ), nuclear receptors regulating the expression of many genes involved in lipid and glucose …

    wayne-thes Repository record for The Effect Of Pioglitazone On Phosphoproteome And Interactome Of Protein Phosphatase 2a In Primary Human Skeletal Muscle Cells (opens in a new tab)

  6. D-Galactose Decreases MitoNEET Levels in Liver Cancer Cells: Impact on Cellular Bioenergetics

    … and ROS levels similar to galactose treatment. Pioglitazone, an antidiabetic drug, binds to mitoNEET and ameliorates galactose toxicity. Cellular mitoNEET levels, exposure of cells to galactose medium, and pioglitazone treatment directly influence cellular respiration. To elucidate the role of …

    eiu Repository record for D-Galactose Decreases MitoNEET Levels in Liver Cancer Cells: Impact on Cellular Bioenergetics (opens in a new tab)

  7. Involvement of PFKFB3/iPFK2 in Beneficial Effects of Metformin on 3T3-L1 Adipocytes and Temporal Effects of Pioglitazone on Adipocytes

    … LPS and insulin. Anti-inflammatory effect of pioglitazone at ZT19 was more effective than that at ZT7, while no significant insulin-sensitizing effect was seen at both time points.

    tamu Repository record for Involvement of PFKFB3/iPFK2 in Beneficial Effects of Metformin on 3T3-L1 Adipocytes and Temporal Effects of Pioglitazone on Adipocytes (opens in a new tab)

  8. Anticonvulsant effects of PPAR-gamma activation in an in vitro model of seizure

    … experiments with a PPARγ agonist (pioglitazone) and an antagonist (GW 9662) to test their efficacy in an in vitro model of seizure using high potassium. We observed that pioglitazone delayed the latency to seizure-like events (SLE) onset and decreased the intraSLE frequency by …

    creighton Repository record for Anticonvulsant effects of PPAR-gamma activation in an in vitro model of seizure (opens in a new tab)

  9. Επίδραση της πιογλιταζόνης στο μεταβολισμό των οστών και τη φλεγμονή του πολφού σε διαβητικούς επίμυες

    … aims to investigate the effect of a low-dose pioglitazone regimen on bone mineral density and bone formation- resorption markers in control and diabetic rats. Nitric oxide levels in the dental pulp were also evaluated.Wistar rats were divided into 4 groups: non-diabetic controls, control rats …

    greece Repository record for Επίδραση της πιογλιταζόνης στο μεταβολισμό των οστών και τη φλεγμονή του πολφού σε διαβητικούς επίμυες (opens in a new tab)

  10. Evaluation of the impact of cardiovascular safety concerns of thiazolidinediones on the utilization of oral antidiabetic drugs

    … utilization of the thiazolidinediones (TZDs), pioglitazone and rosiglitazone, and other oral antidiabetic drugs. In May 2007, a meta-analysis was published that found a potential increased risk of myocardial infarction (MI) associated with TZDs, particularly with rosiglitazone. A two-year …

    texas Repository record for Evaluation of the impact of cardiovascular safety concerns of thiazolidinediones on the utilization of oral antidiabetic drugs (opens in a new tab)

  11. Ο ρόλος των αρχέγονων ενδοθηλιακών κυττάρων σε διαβητικούς ασθενείς με και χωρίς στεφανιαία νόσο

    … study was to investigate if theadministration of pioglitazone or perindopril in diabetic patients can modify thenumber of EPCs in the peripheral blood and alter the endothelial function andinflammatory status of these patients.Methods: Fifty type 2 diabetic patients were recruited and were …

    greece Repository record for Ο ρόλος των αρχέγονων ενδοθηλιακών κυττάρων σε διαβητικούς ασθενείς με και χωρίς στεφανιαία νόσο (opens in a new tab)

  12. Assessment and Treatment of Impaired Insulin- Secretion and Action in Type 2 Diabetes

    … I). We also evaluated the effect of a TZD (pioglitazone) and a long-acting insulin (glargine) as add-on in the treatment of patients with T2D, not achieving glycaemic goals when treated with classic anti-diabetic agents on glycaemic control, insulin sensitivity, β-cell function and markers …

    lund Repository record for Assessment and Treatment of Impaired Insulin- Secretion and Action in Type 2 Diabetes (opens in a new tab) Download PDF for Assessment and Treatment of Impaired Insulin- Secretion and Action in Type 2 Diabetes (opens in a new tab)

  13. Mechanisms of Regulation of Proximal Tubule Sodium Transporters in Obesity-Induced Hypertension

    … tubule epithelial cells, we determined whether pioglitazone exerts its effect via direct PPARγ activation. Pioglitazone reduced systolic blood pressure in obese rats while having no effect in lean rats. However, it increased sodium retention in the lean group. Pioglitazone increased Na,K-ATPase …

    odu Repository record for Mechanisms of Regulation of Proximal Tubule Sodium Transporters in Obesity-Induced Hypertension (opens in a new tab)

  14. Regulation of Nutrient Metabolism in Equine Skeletal Muscle and Adipose Tissue

    … the influence of the insulin-sensitizing drug, pioglitazone, and lipopolysaccharide, on nutrient metabolism in skeletal muscle and adipose tissue, and their association with insulin sensitivity. Pioglitazone treatment did not increase insulin sensitivity; however it did increase skeletal muscle …

    vt Repository record for Regulation of Nutrient Metabolism in Equine Skeletal Muscle and Adipose Tissue (opens in a new tab)

  15. Effects of Peroxisome Proliferator-Activated Receptor Gamma (PPARγ) and Fatty Acid-Binding Protein 5 (FABP5) on Addictive Behaviors in Prenatal Ethanol Exposed Rats

    … receptor gamma (PPARγ) agonist pioglitazone treatment during adolescence in reducing addiction risk in PE rats. We also investigated the efficacy of acute Fatty Acid-Binding Protein 5 (FABP5) inhibitors SB-FI-103/ SB-FI-1621 on drug-taking behaviors. The results showed that …

    buffalo Repository record for Effects of Peroxisome Proliferator-Activated Receptor Gamma (PPARγ) and Fatty Acid-Binding Protein 5 (FABP5) on Addictive Behaviors in Prenatal Ethanol Exposed Rats (opens in a new tab)

Page 1 of 5